GPs are often failing to provide patients who are struggling to meet recommended cholesterol levels with a second-line lipid lowering medication, a survey reveals.
The survey found one-third of high-risk patients failed to meet their target level, despite guidelines highlighting the benefits of low-density lipoprotein (LDL-C).
Figures from the survey show just 57 per cent of GPs were likely to prescribe a second-line treatment, despite the high proportion of patients who were not meeting their targets.
Dr Chrys Michaeliedes, a GP with a specialist interest in diabetes, said doctors needed to be more proactive in their treatment of high-risk patients.
“We need to be more proactive and pay closer attention to LDL-C and find out which of our high-risk patients are not achieving LDL-C...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.